Phenotypic differences between cord blood and adult peripheral blood

Cytometry Part B - Clinical Cytometry

Volumn 76, Issue 1, 2009, Pages 37-46

  López, María C ^a   Palmer, Brent E ^b   Lawrence, David A ^a  

^a WADSWORTH CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Adult peripheral blood; B cells; CD45 expression; Cord blood; Immunophenotype; NK cells; NKT cells; T cells

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN;

AGE DISTRIBUTION; ARTICLE; B LYMPHOCYTE; CD34 SELECTION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTER; FLUOROCHROME STAINING; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; NATURAL KILLER CELL; NATURAL KILLER T CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD;

ADULT; ANTIGENS, CD45; B-LYMPHOCYTES; BIOLOGICAL MARKERS; FETAL BLOOD; FLOW CYTOMETRY; GLUCOCORTICOID-INDUCED TNFR-RELATED PROTEIN; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; PHENOTYPE; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 62349108951     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20441     Document Type: Article

References (44)

1. Levy O, Zarember KA, Roy RM, Cywes C, Godowski PJ, Wessels MR. Selective impairment of TLR-mediated innate immunity in human newborns: Neonatal blood plasma reduces monocytes TNFα induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J Immunol 2004;173: 4627-4634.
2. Velilla PA, Rugeles MT, Chougnet CA. Defective antigen-presenting cell function in human neonates. Clin Immunol 2006;121:251-259.
3. Zinkernagel RM. Maternal antibodies, childhood infections, and autoimmune diseases. N Engl J Med 2001;345:1331-1335.
4. Langrish CL, Buddle JC, Thrasher AJ, Goldblatt D. Neonatal dendritic cells are intrinsically biased against Th-1 immune responses. Clin Exp Immunol 2002;128:118-123.
5. Encabo A, Solves P, Carbonell-Uberos F, Miñana MD. The functional immaturity of dendritic cells can be relevant to increased tolerance associated with cord blood transplantation. Transfusion 2007;47:272-279.
6. Aksoy E, Albarani V, Nguyen M, Laes J-F, Ruelle J-L, De Wit D, Willems F, Goldman M, Goriely S. Interferon regulatory factor 3-dependent responses to lipopolysaccharide are selectively blunted in cord blood cells. Blood 2007;109:2887-2893.
7. Broxmeyer HE, Kurtzberg J, Gluckman E, Auerbach Ad, Douglas G, Cooper S, Falkenburg JH, Bard J, Boyse EA. Umbilical cord blood hematopoietic stem and repopulating cells in human transplantation. Blood cells 1991;17:313-329.
8. + regulatory T (Treg) cells: A comparative study of naïve and antigenic-specific cord blood Treg cells. Exp Hematol 2005;33:1508-1520.
9. + regulatory T cells from the same cord blood unit. Exp Hematol 2007;35:1562-1566.
10. Qian JX, Lee SM, Suen Y, Knoppel E, van de Ven C, Cairo MS. Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood. Blood 1997;90:3106-3117.
11. Dalle J-H, Menezes J, Wagner E, Blagdon M, Champagne J, Champagne MA, Duval M. Characterization of cord blood natural killer cells: Implications for transplantation and neonatal infections. Pediatr Res 2005;57:649-655.
12. Theilgaard-Mönch K, Raaschou-Jensen K, Palm H, Schjødt K, Heilmann C, Vindeløv L, Jacobsen N, Dickmeiss E. Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts. Bone Marrow Transplant 2001;28:1073-1082.
13. Gardiner CM, O'Meara A, Reen DJ. Differential cytotoxicity of cord blood and bone marrow-derived natural killer cells. Blood 1998;91: 207-213.
14. Xu D, Komai-Koma M, Liew FY. Expression of Toll-like receptor on T cells. Cell Immunol 2005;233:85-89.
15. Sutmuller RPM, Morgan ME, FNetea MG, Grauer O, Adema GJ. Toll-like receptors on regulatory T cells: Expanding immune regulation. Trends Immunol 2006;27:387-393.
16. + thymocytes, and B cell maturation. J Exp Med 1996; 183:1707-1718.
17. López MC, Holmes N. Phenotypical and functional alterations in the mucosal immune system of CD45 exon 9 KO mice. Int Immunol 2005;17:15-25.
18. Kung C, Pingel JT, Heikinheimo M, Klemola T, Varkila K, Yoo L, Vuopala K, Poyhonen M, Uhari M, Rogers M, Speck SH, Chatila T, Thomas ML. Mutations in the tyrosine phospatase CD45 gene in a child with severe combined immunodeficiency disease. Nat Med 2000;6:343-345.
19. Tchilian EZ, Wallace DL, Wells RS, Flower G, Morgan G, Beverley PC. A deletion in the gene encoding for CD45 antigen in a patient with SCID. J Immunol 2001;166:1308-1313.
20. Hermiston ML, Xu Z, Weiss A. CD45: A critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 2003;21:107-137.
21. Zamoyska R. Why is there so much CD45 on T cells? Immunity 2007;27:421-423.
22. Tavian M, Hallais M-F, Péault B. Emergence of intraembryonic hematopoietic precursors in the pre-liver human embryo. Development 1999;126:793-803.
23. +-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 2005;105:750-758.
24. + regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy. Blood 2005;106:3068-3073.
25. Nocentini G, Ronchetti S, Cuzzocrea S, Riccardi C. GITR/GITRL: More than an effector T cell co-stimulatory system. Eur J Immunol 2007;37:1165-1169.
26. Hanabuchi S, Watanabe N, Wang Y-H, Wang Y-H, Ito T, Shaw J, Cao W, Qin FX-F, Liu Y-J. Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL). Blood 2006;107:3617-3623.
27. Baltz KM, Krusch M, Bringmann A, Brossart P, Mayer F, Kloss M, Baessler T, Kumbier I, Peterfi A, Kupka S, Kroeber S, Menzel D, Radsak MP, Rammensee H-G, Salih HR. Cancer immunoediting by GITR (glucocorticoid-induced TNF-related protein) ligand in humans: NK cell/ tumor cell interactions. FASEB J 2007;21:2442-2454.
28. D'Arena G, Cascavilla N, Di Giorgio G, Fusilli S, Zendoli F, Carotenuto M, Musto P. Flow cytometric characterization of human umbilical cord blood lymphocytes: Immunophenotypic features. Haematologica 1998;83:197-203.
29. Beck R, Lam-Po-Tang PR. Comparison of cord blood and adult blood lymphocyte normal ranges: A possible explanation for decreased severity of graft versus host disease after cord blood transplantation. Immunol Cell Biol 1994;72:440-444.
30. + NKT lymphocytes are activated memory cells. Eur J Immunol 2000; 30:1544-1550.
31. Berzins SP, Cochrane AD, Pellicci DG, Smyth MJ, Godfrey DI. Limited correlation between human thymus and blood NKT cell content revealed by an ontogeny study of paired samples. Eur J Immunol 2005;35:1399-1407.
32. Lee PT, Benlagha K, Teyton L, Bendelac A. Distinct functional lineages of human V (alpha) 24 natural killer T cells. J Exp Med 2002; 195:637-641.
33. + regulatory T cells suppress NKT cell functions. Cancer Res 2003;63:4516-4520.
34. La Cava A, Van Kaer L, Shi F-D. CD4+CD25+ T regs and NKT cells: Regulators regulating regulators. Trends Immunol 2006; 27: 322-327.
35. Phillips JH, Hori T, Nagler A, Bhat N, Spits H, Lanier LL. Ontogeny of human natural killer (NK) cells: Fetal NK cells mediate cytolytic function and express cytoplasmic CD3ε,δ proteins. J Exp Med 1992;175:1055-1066.
36. Lanier LL, Spits H, Phillips JH. The developmental relationship between NK cells and T cells. Immunol Today 1992;13:392-395.
37. Comans-Bitter WM, de Groot R, van den Beemd R, Neijens HJ, Hope WC, Groeneveld K, Hooijkaas H, van Dongen JJ. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr 1997;130:388-393.
38. Gaddy J, Broxmeyer HE. Cord Blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells. Cell Immunol 1997;180:132-142.
39. Ishii KJ, Coban C, Akira S. Manifold mechanisms of toll-like receptor-ligand recognition. J Clin Immunol 2005;25:511-520.
40. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005;17:1-14.
41. Sadeghi K, Berger A, Langgartner M, Prusa A-R, Hayde M, Herkner K, Pollak A, Spittler A, Förster-Waldl E. Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. J Infect Dis 2007;195:296-302.
42. Komai-Koma M, Jones L, Ogg GS, Xu D, Liew FY. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc Natl Acad Sci USA 2004;101:3029-3034.
43. Eriksson M, Meadows SK, Basu S, Mselle TF, Wira CR, Sentman CL. TLRs mediate IFN-γ production by human uterine NK cells in endometrium. J Immunol 2006;176:6219-6224.
44. De Wit D, Tonon S, Olislagers V, Goriely S, Boutriaux M, Goldman M, Willems F. Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood. J Autoimmun 2003; 21:277-281.